Literature DB >> 6660859

Cyclosporin A inhibits Coccidioides immitis in vitro and in vivo.

T N Kirkland, J Fierer.   

Abstract

BALB/c mice infected intraperitoneally with Coccidioides immitis were treated with cyclosporin (CyA) subcutaneously. CyA prevented infection when treatment was started at day zero. When treatment was delayed until day 6 after infection, the mice that received either 75 or 25 mg/kg per day survived, but those treated with 7.5 mg/kg per day had the same mortality rate as controls. The higher doses of CyA prevented dissemination of the fungus from the peritoneum to the lung but did not eliminate the peritoneal infection. In vitro, CyA inhibited the growth of the mycelial phase of eight test strains of C. immitis at a concentration of 1.0 microgram/ml. One or two strains of 10 other fungi were tested for susceptibility to CyA; only Aspergillus niger was inhibited, at a concentration of 0.1 microgram/ml. CyA is structurally unrelated to the polyenes and imidazoles and has a very restricted spectrum of antifungal activity. CyA may represent a new class of antifungal agents with a novel mechanism of antifungal activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6660859      PMCID: PMC185408          DOI: 10.1128/AAC.24.6.921

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Inhibition of Coccidioides immitis in vitro and enhancement of antiococcidiodial effects of amphotericin B by polymyxin B.

Authors:  S Collins; D Pappagians
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

2.  Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.

Authors:  H A Walch; A Kalvoda
Journal:  Sabouraudia       Date:  1971-11

3.  Mechanisms of resistance to infection with Coccidioides immitis in mice.

Authors:  L V Beaman; D Pappagianis; E Benjamini
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

Review 4.  Strategies in the treatment of systemic fungal infections.

Authors:  G Medoff; G S Kobayashi
Journal:  N Engl J Med       Date:  1980-01-17       Impact factor: 91.245

5.  Antischistosomal effects of cyclosporin A.

Authors:  E Bueding; J Hawkins; Y N Cha
Journal:  Agents Actions       Date:  1981-07

6.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

7.  Ketoconazole in early and late murine coccidioidomycosis.

Authors:  H B Levine; J M Cobb
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

8.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

Authors:  P Donatsch; E Abisch; M Homberger; R Traber; M Trapp; R Voges
Journal:  J Immunoassay       Date:  1981

9.  Ketoconazole for treatment of disseminated coccidioidomycosis.

Authors:  A Catanzaro; H Einstein; B Levine; J B Ross; R Schillaci; J Fierer; P J Friedman
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

  9 in total
  15 in total

1.  In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.

Authors:  Eric Dannaoui; Patrick Schwarz; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

Review 2.  Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.

Authors:  K N Sorensen; K V Clemons; D A Stevens
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 3.  Signal transduction cascades regulating fungal development and virulence.

Authors:  K B Lengeler; R C Davidson; C D'souza; T Harashima; W C Shen; P Wang; X Pan; M Waugh; J Heitman
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

4.  Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.

Authors:  O Marchetti; P Moreillon; M P Glauser; J Bille; D Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Effects of cyclosporine in experimental cryptococcal meningitis.

Authors:  J R Perfect; D T Durack
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

Review 6.  Coccidioidomycosis.

Authors:  J N Galgiani
Journal:  West J Med       Date:  1993-08

7.  Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.

Authors:  J Berenguer; N M Ali; M C Allende; J Lee; K Garrett; S Battaglia; S C Piscitelli; M G Rinaldi; P A Pizzo; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

8.  In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei.

Authors:  Dongdong Mo; Xin Li; Lili Wei; Chenghang Sun; Hao Liang; Cunwei Cao
Journal:  Mycopathologia       Date:  2014-07-23       Impact factor: 2.574

9.  Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model.

Authors:  C H Mody; G B Toews; M F Lipscomb
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

10.  Comparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis.

Authors:  J Fierer; T Kirkland; F Finley
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.